Skip to main content
. 2018 Jul 10;3:83. [Version 1] doi: 10.12688/wellcomeopenres.14691.1

Table 4. Daily number of fixed dose tablet in the control arm (arm R10PO) during week 0–8 and for all arms during the continuation phase of treatment.

Weight Intensive Phase (week 0–8) Continuation Phase
(month 3–12)
RHZE fixed dose combination daily
(150/75/400/275 mg) 3
RH (150/75) 3 RH (300/150) 3
30–37 kg 2 tabs 2 tabs
38–54 kg 3 tabs 3 tabs
55–70 kg 4 tabs 2 tabs
≥ 71 kg 5 tabs 2 tabs